Biotechnology

Techseriesinsight > Blog > News > Biotechnology

February 20, 2026
Business Wire
Biotechnology, News

Sai Life Sciences to Hire 700+ Professionals in FY27 Expansion

Sai Life Sciences hiring FY27 plans signal strong growth in India’s CRDMO sector. Sai Life Sciences announced it will recruit more than 700 scientific, technical, and management professionals during...

February 20, 2026
Business Wire
Biotechnology, News

FDA Accepts Giredestrant NDA for ESR1-Mutated Breast Cancer

Giredestrant NDA has been accepted by the U.S. Food and Drug Administration for review in patients with ESR1-mutated, ER-positive advanced breast cancer. Genentech, a member of the Roche Group,...

February 19, 2026
Business Wire
Biotechnology, News

Brenus Pharma Highlights STC-1010 Data at AACR Immuno-Oncology 2026

Brenus Pharma presented new preclinical and early clinical data on STC-1010 in colorectal cancer at the American Association for Cancer Research Immuno-Oncology (AACR IO) Conference 2026 in Los Angeles...

February 19, 2026
Business Wire
Biotechnology, News

ENHERTU Type II Variation Validated by EMA for HER2 Positive Early Breast Cancer

The ENHERTU Type II Variation application has received validation from the European Medicines Agency (EMA) for use as a post-neoadjuvant treatment in adults with HER2 positive early breast cancer....

February 18, 2026
Business Wire
Biotechnology, News

Sensei Biotherapeutics Acquisition of Faeth and $200M Private Placement

Sensei Biotherapeutics, Inc. has completed the Sensei Biotherapeutics acquisition of Faeth Therapeutics and announced a concurrent $200 million private placement. This strategic move expands Sensei’s oncology pipeline while strengthening...

February 18, 2026
PRNewswire
Biotechnology, News

Bioiberica Wins 2025 European Innovation Award for Native Type II Collagen

Bioiberica has won the 2025 European New Product Innovation Award from Frost & Sullivan for its clinically validated Native Type II Collagen ingredient, Collavant® n2. This recognition highlights the...

February 17, 2026
Business Wire
Biotechnology, News

ImmunityBio Advances Regulatory Plans with SFDA Under Saudi-USA Biotech Alliance

ImmunityBio SFDA regulatory engagement took center stage in Riyadh as ImmunityBio met with the Saudi Food and Drug Authority (SFDA) during the Saudi-USA Biotech Alliance meeting hosted by the...

February 17, 2026
Business Wire
Biotechnology, News

Sensorion Announces CEO Transition and Interim Leadership Appointment

The Sensorion CEO transition marks a significant leadership update for Sensorion (FR0012596468 – ALSEN), a clinical-stage biotechnology company developing innovative therapies for hearing loss disorders. The company confirmed that...

February 16, 2026
Business Wire
Biotechnology, News

Worldwide Clinical Trials Completes Catalyst Acquisition

Worldwide Clinical Trials acquisition marks a significant expansion in the global contract research organization (CRO) landscape. Worldwide Clinical Trials has officially completed its acquisition of Catalyst Clinical Research, a...

February 16, 2026
Business Wire
Biotechnology, News

Nucleome Therapeutics Appoints Dr. Michelle Morrow as Chief Scientific Officer

Nucleome Therapeutics CSO appointment marks a significant leadership milestone as Nucleome Therapeutics names Dr. Michelle Morrow as its new Chief Scientific Officer, effective 23 February 2026. The appointment strengthens...